Investigating STAT3 as a Driver of Pathology in Periodontitis

Plain-language summary

This study investigates the role of the protein STAT3 in the development of periodontitis (an inflammatory gum disease). It enrolled 18-year-old individuals in good general health with no other conditions such as diabetes. It was a study without a phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

University of Chile

Intervention

no intervention

Start date

3/20/2019

Estimated completion

10/20/2022

Countries

Chile

Related genes

Locations

• Santiago, Chile

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* 18-year-old, in good general health, and had no significant medical history.
* no history of diabetes or other diseases different than periodontitis.

Exclusion Criteria:

* Pregnancy and lactation
* Use of antibiotics, immunosuppressive agents, or probiotics within 3 months.